Tirzepatide is a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) https://ronaldtufa303242.azzablog.com/40992063/tirzepatide-a-new-frontier-in-diabetes-treatment